Despite a high degree of worry about COVID and experience with severe, long-lasting symptoms, high-risk patients often do not ...
Immunis Inc. has struck a licensing deal with Japanese material manufacturer Toray Industries Inc. to develop a potential treatment for Parkinson’s-associated involuntary movement.
The Canadian Press on MSN
Today-History-Mar31
--- ...
A federal judge on Monday blocked key parts of Health Secretary Robert F. vaccine policy, including a move to reduce the number of shots routinely recommended for ...
March 16 (Reuters) - A U.S. judge on Monday blocked key parts of Health Secretary Robert F. Kennedy Jr.'s effort to reshape U.S. vaccine policy, including a move to reduce the number of shots ...
(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...
1don MSNOpinion
Act now! Invest in cancer research with BioNTech, Vidac Pharma, and Pfizer and secure returns
BioNTech – In the Midst of a Realignment Things are going well for BioNTech right now, but no longer at a breakneck pace. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results